| Application number | Title of the application | Filing Date | Status |
|---|
| 09/648310 | Progression suppressed gene 13 (PSGen13) and uses thereof | Aug 24, 2000 | Abandoned |
Array
(
[id] => 982359
[patent_doc_number] => 06927203
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-09
[patent_title] => 'Treatment of metastatic disease'
[patent_app_type] => utility
[patent_app_number] => 09/640935
[patent_app_country] => US
[patent_app_date] => 2000-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 6
[patent_no_of_words] => 5960
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/927/06927203.pdf
[firstpage_image] =>[orig_patent_app_number] => 09640935
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/640935 | Treatment of metastatic disease | Aug 16, 2000 | Issued |
| 09/633147 | Polypeptides with Fc binding ability | Aug 3, 2000 | Abandoned |
Array
(
[id] => 707834
[patent_doc_number] => 07060667
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-06-13
[patent_title] => 'Treatment of follicular lymphomas using inhibitors of the LT pathway'
[patent_app_type] => utility
[patent_app_number] => 09/626219
[patent_app_country] => US
[patent_app_date] => 2000-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8051
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 10
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/060/07060667.pdf
[firstpage_image] =>[orig_patent_app_number] => 09626219
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/626219 | Treatment of follicular lymphomas using inhibitors of the LT pathway | Jul 25, 2000 | Issued |
| 09/619285 | Chimeric polypeptides of serum albumin and uses related thereto | Jul 18, 2000 | Abandoned |
Array
(
[id] => 1107451
[patent_doc_number] => 06808924
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-26
[patent_title] => 'Mouse mammary tumor lines expressing estrogen and progesterone receptors'
[patent_app_type] => B1
[patent_app_number] => 09/613707
[patent_app_country] => US
[patent_app_date] => 2000-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 20
[patent_no_of_words] => 7517
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/808/06808924.pdf
[firstpage_image] =>[orig_patent_app_number] => 09613707
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/613707 | Mouse mammary tumor lines expressing estrogen and progesterone receptors | Jul 10, 2000 | Issued |
| 09/613430 | Cancer treatment using angiopoietins targeted to aminophospholipids | Jul 9, 2000 | Abandoned |
Array
(
[id] => 484663
[patent_doc_number] => 07217421
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-05-15
[patent_title] => 'Cancer-associated antigens and methods of their identification and use'
[patent_app_type] => utility
[patent_app_number] => 09/610891
[patent_app_country] => US
[patent_app_date] => 2000-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 14895
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 111
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/217/07217421.pdf
[firstpage_image] =>[orig_patent_app_number] => 09610891
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/610891 | Cancer-associated antigens and methods of their identification and use | Jul 5, 2000 | Issued |
Array
(
[id] => 733444
[patent_doc_number] => 07038028
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-05-02
[patent_title] => 'Gene encoding promoter domain of tumor suppressor gene P51 and use thereof'
[patent_app_type] => utility
[patent_app_number] => 10/030294
[patent_app_country] => US
[patent_app_date] => 2000-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 9360
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/038/07038028.pdf
[firstpage_image] =>[orig_patent_app_number] => 10030294
[rel_patent_id] =>[rel_patent_doc_number] =>) 10/030294 | Gene encoding promoter domain of tumor suppressor gene P51 and use thereof | Jun 27, 2000 | Issued |
Array
(
[id] => 645067
[patent_doc_number] => 07118889
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-10
[patent_title] => 'Protein tyrosine kinase substrate LAT and its use in the indentification of (ant)agonists of the kinase'
[patent_app_type] => utility
[patent_app_number] => 09/597920
[patent_app_country] => US
[patent_app_date] => 2000-06-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 46
[patent_no_of_words] => 32253
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/118/07118889.pdf
[firstpage_image] =>[orig_patent_app_number] => 09597920
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/597920 | Protein tyrosine kinase substrate LAT and its use in the indentification of (ant)agonists of the kinase | Jun 18, 2000 | Issued |
Array
(
[id] => 979171
[patent_doc_number] => 06930175
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-08-16
[patent_title] => 'Gene family with transformation modulating activity'
[patent_app_type] => utility
[patent_app_number] => 09/591500
[patent_app_country] => US
[patent_app_date] => 2000-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 14
[patent_no_of_words] => 16240
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/930/06930175.pdf
[firstpage_image] =>[orig_patent_app_number] => 09591500
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/591500 | Gene family with transformation modulating activity | Jun 11, 2000 | Issued |
Array
(
[id] => 1059601
[patent_doc_number] => 06852691
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-02-08
[patent_title] => 'Anti-angiogenic peptides and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 09/589777
[patent_app_country] => US
[patent_app_date] => 2000-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 41
[patent_no_of_words] => 25235
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/852/06852691.pdf
[firstpage_image] =>[orig_patent_app_number] => 09589777
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/589777 | Anti-angiogenic peptides and methods of use thereof | Jun 7, 2000 | Issued |
Array
(
[id] => 383191
[patent_doc_number] => 07307143
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-12-11
[patent_title] => 'Conductin protein and a related agent for diagnosing and treating tumor illnesses'
[patent_app_type] => utility
[patent_app_number] => 09/587574
[patent_app_country] => US
[patent_app_date] => 2000-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 1910
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/307/07307143.pdf
[firstpage_image] =>[orig_patent_app_number] => 09587574
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/587574 | Conductin protein and a related agent for diagnosing and treating tumor illnesses | Jun 4, 2000 | Issued |
Array
(
[id] => 1328048
[patent_doc_number] => 06599912
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-07-29
[patent_title] => 'Methods and compositions for modulating cell proliferation and cell death'
[patent_app_type] => B1
[patent_app_number] => 09/587559
[patent_app_country] => US
[patent_app_date] => 2000-06-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 8
[patent_no_of_words] => 43765
[patent_no_of_claims] => 40
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/599/06599912.pdf
[firstpage_image] =>[orig_patent_app_number] => 09587559
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/587559 | Methods and compositions for modulating cell proliferation and cell death | Jun 4, 2000 | Issued |
Array
(
[id] => 1096748
[patent_doc_number] => 06822083
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-11-23
[patent_title] => 'TSA305 gene'
[patent_app_type] => B1
[patent_app_number] => 09/555367
[patent_app_country] => US
[patent_app_date] => 2000-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10459
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/822/06822083.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555367
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555367 | TSA305 gene | May 29, 2000 | Issued |
Array
(
[id] => 1014809
[patent_doc_number] => 06894153
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-05-17
[patent_title] => 'Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells'
[patent_app_type] => utility
[patent_app_number] => 09/674436
[patent_app_country] => US
[patent_app_date] => 2000-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 14
[patent_no_of_words] => 18367
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/894/06894153.pdf
[firstpage_image] =>[orig_patent_app_number] => 09674436
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/674436 | Gene Any-RF; dormancy regulatory substance, process for producing the same and cell regulator for vital cells | May 25, 2000 | Issued |
Array
(
[id] => 1115164
[patent_doc_number] => 06800436
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-05
[patent_title] => 'Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene'
[patent_app_type] => B1
[patent_app_number] => 09/555166
[patent_app_country] => US
[patent_app_date] => 2000-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 18127
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/800/06800436.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555166
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555166 | Diagnostic method, diagnostic reagent and therapeutic preparation for diseases caused by variation in LKB1 gene | May 24, 2000 | Issued |
| 09/576455 | 46745, a novel human acyltransferase family member and uses thereof | May 22, 2000 | Abandoned |
Array
(
[id] => 1151270
[patent_doc_number] => 06767720
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-07-27
[patent_title] => 'CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation'
[patent_app_type] => B1
[patent_app_number] => 09/574779
[patent_app_country] => US
[patent_app_date] => 2000-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 30
[patent_no_of_words] => 36600
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/767/06767720.pdf
[firstpage_image] =>[orig_patent_app_number] => 09574779
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/574779 | CDNAs encoding catenin-binding proteins with function in signalling and/or gene regulation | May 18, 2000 | Issued |
Array
(
[id] => 529342
[patent_doc_number] => 07179588
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-02-20
[patent_title] => 'Assay for the detection of paclitaxel resistant cells in human tumors'
[patent_app_type] => utility
[patent_app_number] => 09/574099
[patent_app_country] => US
[patent_app_date] => 2000-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 24479
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/179/07179588.pdf
[firstpage_image] =>[orig_patent_app_number] => 09574099
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/574099 | Assay for the detection of paclitaxel resistant cells in human tumors | May 17, 2000 | Issued |